JTC Team, LLC (NASDAQ:VLON)

BRIEF

published on 07/24/2024 at 19:29, 4 months 27 days ago

Sonnet BioTherapeutics (NASDAQ:SONN) Participates in JTC Team's Virtual Investor Segment

Clinical Trial Sonnet BioTherapeutics Immunotherapeutic Drugs Virtual Investor JTC Team
PRESS RELEASE

published on 07/24/2024 at 19:24, 4 months 27 days ago

Sonnet BioTherapeutics (NASDAQ:SONN) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
JTC Team releases 'What This Means' segment featuring Sonnet BioTherapeutics discussing encouraging data from ongoing clinical trial. Virtual presentation available now

Investor Relations Clinical Trial Sonnet BioTherapeutics Immunotherapeutic Drugs JTC Team
BRIEF

published on 06/17/2024 at 14:05, 6 months 4 days ago

Final Line-Up Announced for JTC Team’s Virtual Investor Pitch Conference

Virtual Conference JTC Team Investor Pitch Company Line-Up
PRESS RELEASE

published on 06/17/2024 at 14:00, 6 months 4 days ago

Final Participating Company Line-Up Announced for the Virtual Investor Pitch Conference Hosted by JTC Team Being Held June 17 - 18, 2024
JTC announces final line-up for Virtual Investor Pitch Conference on June 17-18, 2024, featuring live webcast presentations by various companies at www.virtualinvestorco.com

Investor Relations JTC Team Virtual Investor Pitch Conference Webcast Presentations Event Schedule
BRIEF

published on 06/12/2024 at 16:05, 6 months 9 days ago

Outlook Therapeutics (NASDAQ: OTLK) to Participate in Virtual Investor Closing Bell Series

Webcast Outlook Therapeutics Virtual Investor Closing Bell Series Russell Trenary ONS-5010
PRESS RELEASE

published on 06/12/2024 at 16:00, 6 months 9 days ago

Outlook Therapeutics(R) (NASDAQ: OTLK) to Participate Virtual Investor Closing Bell Series
Outlook Therapeutics, Inc. to participate in virtual investor event hosted by JTC Team, providing corporate overview and business outlook on June 13, 2024 at 4:00 PM ET

Investor Event JTC Team Outlook Therapeutics Virtual Webcast Retina Diseases
BRIEF

published on 06/10/2024 at 14:05, 6 months 11 days ago

JTC Team Announces Participating Company Line-Up for the Virtual Investor Pitch Conference on June 17-18, 2024

Investor Relations Live Webcast Virtual Conference Financial Events JTC Team 10:00 AM ET: Adolore BioTherapeutics – Webcast 11:00 AM ET: CNS Pharmaceuticals, Inc. – Webcast 12:00 PM ET: Palisade Bio, Inc. – Webcast 1:00 PM ET: AIM ImmunoTech Inc. – Webcast 4:00 PM ET: EnVVeno Medical Corporation – Webcast 10:00 AM ET: Royalty Management Holding Corporation – Webcast 11:00 AM ET: GRI Bio, Inc. – Webcast 12:00 PM ET: Outlook Therapeutics, Inc. – Webcast 1:00 PM ET: American Resources Corporation – Webcast 3:00 PM ET: Moleculin Biotech, Inc. – Webcast
PRESS RELEASE

published on 06/10/2024 at 14:00, 6 months 11 days ago

JTC Team Announces Participating Company Line-Up for the Virtual Investor Pitch Conference on June 17-18, 2024
JTC Team to host Virtual Investor Pitch Conference on June 17-18, 2024, featuring live webcast presentations with Q&A sessions. Participating companies include Adolore BioTherapeutics, CNS Pharmaceuticals, Palisade Bio, AIM ImmunoTech, enVVeno Medical, Royalty Management Holding, GRI Bio, Outlook Therapeutics, American Resources Corp, and Moleculin Biotech

Investor Relations JTC Team Virtual Investor Pitch Conference Webcast Presentations Participating Companies
BRIEF

published on 06/06/2024 at 16:35, 6 months 15 days ago

Outlook Therapeutics Receives European Authorization for LYTENAVA™

JTC Team Outlook Therapeutics LYTENAVA™ European Authorization Wet AMD
PRESS RELEASE

published on 06/06/2024 at 16:30, 6 months 15 days ago

Outlook Therapeutics(R) (NASDAQ:OTLK) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
Outlook Therapeutics receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for wet AMD treatment. Watch the 'What This Means' video featuring CEO Russ Trenary

European Commission JTC Team Outlook Therapeutics LYTENAVA Wet AMD Treatment

Published on 12/21/2024 at 01:30, 17 hours 20 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 20 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 45 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 18 hours 50 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 20 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 17 hours 58 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 5 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 39 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 23 hours 54 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 32 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 4 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News